Literature DB >> 18768824

Cutting edge: programmed death-1 up-regulation is involved in the attrition of cytomegalovirus-specific CD8+ T cells in acute self-limited hepatitis B virus infection.

Ji-Yuan Zhang1, Zheng Zhang, Bo Jin, Shu-Ye Zhang, Chun-Bao Zhou, Jun-Liang Fu, Fu-Sheng Wang.   

Abstract

Attrition of heterologous virus-specific CD8(+) T cells has been demonstrated in murine viral infection; however, little is known regarding this phenomenon in human viral infections. In this study, we observed that CMV-specific CD8(+) T cells displayed numerical decline and functional impairment in the early phase of acute infection, whereas programmed death-1 (PD-1) expression was significantly up-regulated by these CMV-specific CD8(+) T cells. This early PD-1 up-regulation was found to be closely associated with the increased apoptotic sensitivity of CMV-specific CD8(+) T cells. The in vitro addition of anti-PD-1 further enhanced the spontaneous apoptosis of CMV-specific CD8(+) T cells; however, blockade of the PD-1-mediated pathway with anti-PD-L1 significantly restored the CMV-specific CD8(+) T cell proliferation and IFN-gamma production. Thus, PD-1 plays a crucial role in the attrition of CMV-specific CD8(+) T cells in acute hepatitis B virus infection, which in turn, influences the preexisting homeostatic virus-specific CD8(+) T cell pool.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18768824     DOI: 10.4049/jimmunol.181.6.3741

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Transient CD8-memory contraction: a potential contributor to latent cytomegalovirus reactivation.

Authors:  Jonathan Campbell; Joanne Trgovcich; Michelle Kincaid; Peter D Zimmerman; Paul Klenerman; Stuart Sims; Charles H Cook
Journal:  J Leukoc Biol       Date:  2012-06-22       Impact factor: 4.962

Review 2.  The two faces of heterologous immunity: protection or immunopathology.

Authors:  Shalini Sharma; Paul G Thomas
Journal:  J Leukoc Biol       Date:  2013-11-08       Impact factor: 4.962

3.  Up-regulation of Tim-3 expression contributes to development of burn-induced T cell immune suppression in mice.

Authors:  Zhaohui Tang; Yan Yu; Wenhong Qiu; Jian Zhang; Xiangping Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-10-25

Review 4.  Virological and Immunological Outcomes of Coinfections.

Authors:  Naveen Kumar; Shalini Sharma; Sanjay Barua; Bhupendra N Tripathi; Barry T Rouse
Journal:  Clin Microbiol Rev       Date:  2018-07-05       Impact factor: 26.132

5.  Contribution of herpesvirus specific CD8 T cells to anti-viral T cell response in humans.

Authors:  Elena Sandalova; Diletta Laccabue; Carolina Boni; Anthony T Tan; Katja Fink; Eng Eong Ooi; Robert Chua; Bahar Shafaeddin Schreve; Carlo Ferrari; Antonio Bertoletti
Journal:  PLoS Pathog       Date:  2010-08-19       Impact factor: 6.823

6.  Decreased ratio of Treg cells to Th17 cells correlates with HBV DNA suppression in chronic hepatitis B patients undergoing entecavir treatment.

Authors:  Ji-Yuan Zhang; Chun-Hui Song; Feng Shi; Zheng Zhang; Jun-Liang Fu; Fu-Sheng Wang
Journal:  PLoS One       Date:  2010-11-08       Impact factor: 3.240

7.  PD-1 regulates T cell proliferation in a tissue and subset-specific manner during normal mouse pregnancy.

Authors:  Michelle T Shepard; Elizabeth A Bonney
Journal:  Immunol Invest       Date:  2013-06-19       Impact factor: 3.657

Review 8.  Herpesvirus exploitation of host immune inhibitory pathways.

Authors:  Gabrielle Stack; Maria A Stacey; Ian R Humphreys
Journal:  Viruses       Date:  2012-08-03       Impact factor: 5.048

9.  T cells from Programmed Death-1 deficient mice respond poorly to Mycobacterium tuberculosis infection.

Authors:  Sultan Tousif; Yogesh Singh; Durbaka Vijaya Raghava Prasad; Pawan Sharma; Luc Van Kaer; Gobardhan Das
Journal:  PLoS One       Date:  2011-05-12       Impact factor: 3.240

10.  Hyper-activated pro-inflammatory CD16 monocytes correlate with the severity of liver injury and fibrosis in patients with chronic hepatitis B.

Authors:  Ji-Yuan Zhang; Zheng-Sheng Zou; Ang Huang; Zheng Zhang; Jun-Liang Fu; Xiang-Sheng Xu; Li-Ming Chen; Bao-Sen Li; Fu-Sheng Wang
Journal:  PLoS One       Date:  2011-03-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.